APA (7th ed.) Citation

Malucchi, S., Perini, P., Rinaldi, F., Radaelli, M., Malentacchi, M., Bertolotto, A., & Di Sapio, A. (2025). Disease Course in Patients Switched from Natalizumab to Alemtuzumab: An Italian Multicenter, Prospective, Observational Study. Neurology & Therapy, 14(4), 1451. https://doi.org/10.1007/s40120-025-00754-6

Chicago Style (17th ed.) Citation

Malucchi, Simona, Paola Perini, Francesca Rinaldi, Marta Radaelli, Maria Malentacchi, Antonio Bertolotto, and Alessia Di Sapio. "Disease Course in Patients Switched from Natalizumab to Alemtuzumab: An Italian Multicenter, Prospective, Observational Study." Neurology & Therapy 14, no. 4 (2025): 1451. https://doi.org/10.1007/s40120-025-00754-6.

MLA (9th ed.) Citation

Malucchi, Simona, et al. "Disease Course in Patients Switched from Natalizumab to Alemtuzumab: An Italian Multicenter, Prospective, Observational Study." Neurology & Therapy, vol. 14, no. 4, 2025, p. 1451, https://doi.org/10.1007/s40120-025-00754-6.